Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Pericapsular Nerve Group (PENG) Block Versus Lumbar Erector Spinae Plane Block as Postoperative Analgesia in Hip Surgeries: A Randomized Controlled Trial

ID
Name
6818
Description
assess and compare the efficacy of pericapsular nerve group block wersus lumber erector spinae plane block in reducing postoperative pain within the first 24 hours after hip surgeries.
Trial arms
Trial start
2021-06-01
Estimated PCD
2021-12-30
Trial end
2022-02-20
Status
Completed
Phase
Early phase I
Treatment
Pericapsular Nerve Block
regional anaesthia
Arms:
PENG
Other names:
PENG
Lumbar Erector Spinae Plane Block
regional anaesthia
Arms:
ESPB
Other names:
LESB
Fentanyl
intavenous
Arms:
control
Size
69
Primary endpoint
the time to first postoperative rescue analgesia
24 hours postoperative
Eligibility criteria
Inclusion Criteria: Aged 65 to 75 years old. American Society of anesthesiologists physical status II and III. Body mass index of 25 to 30 kg/m2. Exclusion Criteria: Altered mental status. History of trauma or multiple fractures Uncontrolled hypertension and or diabetes. Coagulopathy. Preexisting advanced kidney, liver, or heart disease. Allergies or contraindications to the study drugs. Chronic use of opioids or corticosteroids.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE2'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'maskingDescription': 'douple', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER']}}, 'enrollmentInfo': {'count': 69, 'type': 'ACTUAL'}}
Updated at
2023-06-26

1 organization

1 drug

2 indications

Organization
Zagazig University
Drug
Ketamine
Indication
Pericapsular Nerve Group Block
Indication
Lumbar Erector Spinae Plane Block